Skip to main content
Article
Symptom Information in Direct-to-Consumer Antidepressant Advertising and College Students' Perception of the Lifetime Risk Depression
Journal of Medical Marketing
  • Jin Seong Park, Temple University
  • Jean M. Grow, Marquette University
Document Type
Article
Language
eng
Format of Original
11 p.
Publication Date
4-1-2010
Publisher
Palgrave MacMillan
Original Item ID
doi: 10.1057/jmm.2009.44
Disciplines
Abstract

While consumers’ health cognition and behavior are likely formed through multiple influences, the current study focused on the effects of exposure to specific content elements in direct-to-consumer advertising. The study revealed that consumers’ exposure to the American Psychiatric Association’s (APA) diagnostic guideline has potential to reduce their perceived lifetime risk of depression and intention to consult a health professional to discuss the health issue. The study further revealed when an antidepressant ad mentioned a long list of symptoms, exposure to the diagnostic guideline reduced risk perception and consultation intention significantly, whereas in the presence of a short list of symptoms, the APA guideline had minimal impact.

Comments

Accepted version. Journal of Medical Marketing, Vol 10, No. 2 (April 2010): 123-133. DOI. © 2010 Palgrave Macmillan. Used with permission.

This is a post-peer-review, pre-copy edit version of an article published in Journal of Medical Marketing. The definitive publisher-authenticated version Journal of Medical Marketing, Volume 10, No. 2 (April 2010) is available online at: 10.1057/jmm.2009.44.

Citation Information
Jin Seong Park and Jean M. Grow. "Symptom Information in Direct-to-Consumer Antidepressant Advertising and College Students' Perception of the Lifetime Risk Depression" Journal of Medical Marketing (2010) ISSN: 1745-7904
Available at: http://works.bepress.com/jean_grow/8/